NCT04443972

Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement

Evaluation of Injectable Beta- Tricalcium Phosphate as an Occlusive Barrier Membrane in Treatment of Grade ii Furcation Involvement (Clinical and Radiographic Study)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Hams Hamed Abdelrahman · Academic / Other
• Sex: All
• Age: 30 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This study will be conducted to evaluate clinically and radiographically the use of PD VitalOs cement® bone graft in the treatment of class II furcation defects comparing with Hydroxyapatite bone graft and biodegradable collagen membrane in the treatment of class II furcation defects.

Detailed description

The study is a randomized, controlled clinical trial. Patients were randomly divided into two equal groups, Group I (Test group): included seven Grade II furcation defects treated by beta tricalcium phosphate bone cement only. Group II (Control group): included seven Grade II furcation defects treated with granulated beta tricalcium phosphate bone graft covered by resorbable collagen membrane.

Conditions

• Furcation Defects

Interventions

Type	Name	Description
OTHER	PD VitalOs cement®	PD VitalOs cement®\* is a synthetic bone grafting cement designed for bone void filling and bone regeneration in dental surgery
OTHER	Hydroxyapatite bone graft	a bioceramic bone substitute, providing a scaffold for bone deposition
OTHER	biodegardable collagen membrane	provide efficacious barriers that were interposed between the flap and root surface.

Timeline

• Start date: 2018-04-12
• Primary completion: 2019-07-10
• Completion: 2020-02-04
• First posted: 2020-06-23
• Last updated: 2020-06-23

Locations

1 site across 1 country: Egypt